➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKesson
Medtronic
Boehringer Ingelheim
AstraZeneca

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Halcinonide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for halcinonide and what is the scope of patent protection?

Halcinonide is the generic ingredient in three branded drugs marketed by Mylan, Sun Pharm Inds Inc, Westwood Squibb, and Bristol Myers Squibb, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for halcinonide. Three suppliers are listed for this compound.

Summary for halcinonide
Pharmacology for halcinonide
Medical Subject Heading (MeSH) Categories for halcinonide

US Patents and Regulatory Information for halcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc HALOG-E halcinonide CREAM;TOPICAL 018234-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide SOLUTION;TOPICAL 017823-001 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide CREAM;TOPICAL 017556-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc HALOG halcinonide OINTMENT;TOPICAL 017824-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb HALOG halcinonide OINTMENT;TOPICAL 018125-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Harvard Business School
McKesson
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.